{"id":"NCT00391807","sponsor":"Warner Chilcott","briefTitle":"Study of Safety and Efficacy of an Oral Contraceptive","officialTitle":"Open-Label Study of the Safety and Efficacy of a Low Dose Oral Contraceptive Containing Norethindrone Acetate and Ethinyl Estradiol","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2008-08","completion":"2008-09","firstPosted":"2006-10-24","resultsPosted":"2010-12-22","lastUpdate":"2013-04-22"},"enrollment":1683,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"Norethindrone acetate/ethinyl estradiol","otherNames":[]}],"arms":[{"label":"study drug","type":"EXPERIMENTAL"}],"summary":"This is a non-comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding; and to assess the safety and tolerability of the product.","primaryOutcome":{"measure":"Pregnancy Rate (Expressed as Pearl Index) in Women Aged 18 to 35, MITT Population,","timeFrame":"13 cycles, 28 days each (1 year)","effectByArm":[{"arm":"Norethindrone/Ethinyl Estradiol","deltaMin":2.554,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":66,"countries":["United States"]},"refs":{"pmids":["26410176","23921878"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":1660},"commonTop":["Headache","Upper Respiratory Tract Infection","Sinusitis","Nasopharyngitis"]}}